Point-of-care testing for COVID-19 using SHERLOCK diagnosticsJulia Joung(Broad Institute), Feng Zhang(Broad Institute)medRxivMay 8, 202010.1101/2020.05.04.20091231Cited by 335SaveCiteExport RISWatch citationsRelated PapersA transcription factor atlas of directed differentiation|Cell|2023|220CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity|Nature Communications|2022|113